Loading...

Peter Stephen Conti, MD, PhD

TitleProfessor of Radiology
InstitutionUniversity of Southern California
DepartmentRadiology
AddressCSC 103
Health Sciences Campus
Los Angeles CA 90089-9062
Phone+1 323 442 3858
vCardDownload vCard
    Other Positions
    TitleDirector, Molecular Imaging Center

    TitlePet Imaging Center Director


    Collapse Overview 
    Collapse Overview
    Dr. Conti completed his MD at Cornell University Medical College and then went on to Cornell University Graduate School of Medicine to do his Ph.D. in Biophysics. After an Internship in Surgery at St. Lukes Hospital, NY he went on to do his residency in Radiology, and then a fellowship in Nuclear Medicine at John Hopkins Hospital, MD. He joined the staff at USC as a professor of Pharmacy and then Radiology and Biomedical Engineering. Dr. Conti as board certification from the the American Board of Radiology and American Board of Nuclear Medicine.


    Collapse Research 
    Collapse Research Activities and Funding
    IVIS Spectrum Optical Imaging Core Resource
    NIH S10OD021785Apr 15, 2017 - Apr 14, 2018
    Role: Principal Investigator
    Phase Contrast Tomographic X-Ray Microscope System
    NIH S10OD018500Apr 6, 2015 - Apr 5, 2016
    Role: Principal Investigator
    Small Animal Photoacoustic Imaging Unit: Integrating Optical Imaging with High Fr
    NIH S10OD018096Jun 1, 2014 - May 31, 2015
    Role: Principal Investigator
    The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer
    NIH/NIBIB R01EB014354Sep 23, 2013 - Jun 30, 2017
    Role: Co-Principal Investigator
    MicroPET/CT for Small Animal Imaging
    NIH S10OD012371Apr 20, 2013 - Apr 19, 2014
    Role: Principal Investigator
    EphB4 as Novel Target for Breast Cancer Imaging
    NIH/NIBIB R21EB012294May 1, 2011 - Apr 30, 2014
    Role: Principal Investigator
    Cyclotron for Molecular Imaging Program at USC
    NIH/NCRR S10RR029178May 1, 2011 - Apr 30, 2014
    Role: Principal Investigator
    Ultra-High Resolution CT Specimen Scanner for In Vitro Applications
    NIH/NCRR S10RR027665Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    Digital X-Ray Device for Molecular Imaging Center
    NIH/NCRR S10RR027689Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    High Resolution Ultrasound Resource for Molecular Imaging Center
    NIH/NCRR S10RR023653May 1, 2007 - Apr 30, 2008
    Role: Principal Investigator
    Micro Computerized Tomography Imaging System
    NIH/NCRR S10RR019253May 15, 2004 - Dec 30, 2007
    Role: Principal Investigator
    Development of a Cellular and Molecular-Based Cancer Im*
    NIH/NCI P20CA086352Jul 12, 2001 - Jun 30, 2007
    Role: Principal Investigator
    SMALL ANIMAL PET SCANNER FOR CANCER APPLICATIONS
    NIH/NCRR S10RR015703Apr 1, 2001 - Sep 30, 2002
    Role: Principal Investigator
    DUAL HOT CELL SYSTEM AND AUXILLARY EQUIPMENT
    NIH/NCRR S10RR012966Jul 8, 1998 - Jan 7, 2002
    Role: Principal Investigator
    IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES
    NIH/NCI R01CA072896Feb 21, 1997 - Jan 31, 2003
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang X, Zhang J, Wu H, Li Y, Conti P, Chen K. PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. Amino Acids. 2018 Apr 24. PMID: 29691700.
      View in: PubMed
    2. Ma W, Fu F, Zhu J, Huang R, Zhu Y, Liu Z, Wang J, Conti P, Shi X, Chen K. 64Cu-Labeled multifunctional dendrimers for targeted tumor PET imaging. Nanoscale. 2018 Mar 29; 10(13):6113-6124. PMID: 29547220.
      View in: PubMed
    3. Zhou B, Flodby P, Luo J, Castillo DR, Liu Y, Yu FX, McConnell A, Varghese B, Li G, Chimge NO, Sunohara M, Koss MN, Elatre W, Conti P, Liebler JM, Yang C, Marconett CN, Laird-Offringa IA, Minoo P, Guan K, Stripp BR, Crandall ED, Borok Z. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest. 2018 Mar 01; 128(3):970-984. PMID: 29400695.
      View in: PubMed
    4. Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice. Anticancer Res. 2017 02; 37(2):475-479. PMID: 28179292.
      View in: PubMed
    5. Huang R, Conti P, Chen K. In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes. Methods Mol Biol. 2016; 1444:73-84. PMID: 27283419.
      View in: PubMed
    6. Fang J, Xiao L, Joo KI, Liu Y, Zhang C, Liu S, Conti P, Li Z, Wang P. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2016 Feb 15; 138(4):1013-23. PMID: 26334777; PMCID: PMC4715643 [Available on 02/15/17].
    7. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti P, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 2015 Jul 07; 22(1):86-99. PMID: 26094889; PMCID: PMC4509734.
    8. Conti P. Walter Wolf, PhD, 1931-2014. J Nucl Med. 2015 May; 56(5):13N, 18N. PMID: 25934677.
      View in: PubMed
    9. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti P, Gill PS, Li Z. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13. PMID: 25908833.
      View in: PubMed
    10. Jadvar H, Challa S, Quinn DI, Conti P. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer. Cancer Biother Radiopharm. 2015 Jun; 30(5):195-9. PMID: 25746633; PMCID: PMC4492702.
    11. Selvaraj R, Giglio B, Liu S, Wang H, Wang M, Yuan H, Chintala SR, Yap LP, Conti P, Fox JM, Li Z. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation. Bioconjug Chem. 2015 Mar 18; 26(3):435-42. PMID: 25679331; PMCID: PMC4492458.
    12. Huang R, Wang M, Zhu Y, Conti P, Chen K. Development of PET probes for cancer imaging. Curr Top Med Chem. 2015; 15(8):795-819. PMID: 25732787.
      View in: PubMed
    13. Jadvar H, Desai B, Conti P. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015 Jan; 45(1):58-65. PMID: 25475379; PMCID: PMC4258001.
    14. Ma W, Li G, Wang J, Yang W, Zhang Y, Conti P, Chen K. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature. Amino Acids. 2014 Dec; 46(12):2721-32. PMID: 25182731.
      View in: PubMed
    15. Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti P, Sutcliffe JL. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin avß 6. Mol Imaging Biol. 2014 Aug; 16(4):567-77. PMID: 24448825; PMCID: PMC4277820.
    16. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. PMID: 24424460; PMCID: PMC4183751.
    17. Li G, Wang X, Zong S, Wang J, Conti P, Chen K. MicroPET imaging of CD13 expression using a (64)Cu-labeled dimeric NGR peptide based on sarcophagine cage. Mol Pharm. 2014 Nov 03; 11(11):3938-46. PMID: 25054774.
      View in: PubMed
    18. Hu H, Li D, Liu S, Wang M, Moats R, Conti P, Li Z. Integrin a2ß1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging. Biomaterials. 2014 Oct; 35(30):8649-58. PMID: 25043573.
      View in: PubMed
    19. Liu S, Li D, Zhang Z, Surya Prakash GK, Conti P, Li Z. Efficient synthesis of fluorescent-PET probes based on [¹8F]BODIPY dye. Chem Commun (Camb). 2014 Jul 14; 50(55):7371-3. PMID: 24869927.
      View in: PubMed
    20. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti P, Shan H, Li Z. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Mol Pharm. 2014 Nov 03; 11(11):3974-9. PMID: 24978094; PMCID: PMC4224514.
    21. Janib SM, Gustafson JA, Minea RO, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti P, Li Z, MacKay JA. Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules. 2014 Jul 14; 15(7):2347-58. PMID: 24871936; PMCID: PMC4098058.
    22. Wu Z, Liu S, Nair I, Omori K, Scott S, Todorov I, Shively JE, Conti P, Li Z, Kandeel F. (64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression. Theranostics. 2014; 4(8):770-7. PMID: 24955138; PMCID: PMC4063975.
    23. Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti P, Li Z, Kandeel F, Shively JE. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor. J Nucl Med. 2014 Jul; 55(7):1178-84. PMID: 24854793.
      View in: PubMed
    24. Liu S, Li Z, Conti P. Development of multi-functional chelators based on sarcophagine cages. Molecules. 2014 Apr 03; 19(4):4246-55. PMID: 24705567.
      View in: PubMed
    25. Zhu W, Li Q, Bai B, Conti P, Leahy RM. Patlak image estimation from dual time-point list-mode PET data. IEEE Trans Med Imaging. 2014 Apr; 33(4):913-24. PMID: 24710160; PMCID: PMC4209255.
    26. Li G, Xing Y, Wang J, Conti P, Chen K. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide. Amino Acids. 2014 Jun; 46(6):1547-56. PMID: 24652439.
      View in: PubMed
    27. Aluri SR, Shi P, Gustafson JA, Wang W, Lin YA, Cui H, Liu S, Conti P, Li Z, Hu P, Epstein AL, MacKay JA. A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody. ACS Nano. 2014 Mar 25; 8(3):2064-76. PMID: 24484356; PMCID: PMC4004287.
    28. Fei L, Yap LP, Conti P, Shen WC, Zaro JL. Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. Biomaterials. 2014 Apr; 35(13):4082-7. PMID: 24508076; PMCID: PMC3954778.
    29. Xing Y, Zhao J, Conti P, Chen K. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 2014; 4(3):290-306. PMID: 24505237; PMCID: PMC3915092.
    30. Mortimer JE, Bading JR, Colcher DM, Conti P, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. J Nucl Med. 2014 Jan; 55(1):23-9. PMID: 24337604; PMCID: PMC4084518.
    31. Lin Y, Haldar JP, Li Q, Conti P, Leahy RM. Sparsity Constrained Mixture Modeling for the Estimation of Kinetic Parameters in Dynamic PET. IEEE Trans Med Imaging. 2014 Jan; 33(1):173-85. PMID: 24216681; PMCID: PMC4013253.
    32. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 02; 10(12):4527-33. PMID: 24147882; PMCID: PMC3888823.
    33. Jang JK, Khawli LA, Park R, Wu BW, Li Z, Canter D, Conti P, Epstein AL. Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models. Mol Cancer Ther. 2013 Dec; 12(12):2827-36. PMID: 24130055; PMCID: PMC3929394.
    34. Liu S, Li D, Shan H, Gabbaï FP, Li Z, Conti P. Evaluation of ¹8F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging. Nucl Med Biol. 2014 Jan; 41(1):120-6. PMID: 24210284.
      View in: PubMed
    35. Bai B, Bading J, Conti P. Tumor quantification in clinical positron emission tomography. Theranostics. 2013 Oct 07; 3(10):787-801. PMID: 24312151; PMCID: PMC3840412.
    36. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti P, Li Z, Lee AS, Gill PS. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. PMID: 24048331; PMCID: PMC4151476.
    37. Li D, Liu S, Shan H, Conti P, Li Z. Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy. Theranostics. 2013; 3(7):507-15. PMID: 23843898; PMCID: PMC3706694.
    38. Jadvar H, Desai B, Ji L, Conti P, Dorff TB, Groshen SG, Pinski JK, Quinn DI. Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. J Nucl Med. 2013 Aug; 54(8):1195-201. PMID: 23785174; PMCID: PMC3783857.
    39. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. PMID: 23667241.
      View in: PubMed
    40. Liu S, Hassink M, Selvaraj R, Yap LP, Park R, Wang H, Chen X, Fox JM, Li Z, Conti P. Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation. Mol Imaging. 2013 Mar-Apr; 12(2):121-8. PMID: 23415400; PMCID: PMC4027965.
    41. Liu S, Lin TP, Li D, Leamer L, Shan H, Li Z, Gabbaï FP, Conti P. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics. 2013; 3(3):181-9. PMID: 23471211; PMCID: PMC3590587.
    42. Cai H, Conti P. RGD-based PET tracers for imaging receptor integrin av ß3 expression. J Labelled Comp Radiopharm. 2013 May 15; 56(5):264-79. PMID: 24285371.
      View in: PubMed
    43. Joo KI, Xiao L, Liu S, Liu Y, Lee CL, Conti P, Wong MK, Li Z, Wang P. Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials. 2013 Apr; 34(12):3098-109. PMID: 23375392; PMCID: PMC3995748.
    44. Liu S, Park R, Conti P, Li Z. "Kit like" (18)F labeling method for synthesis of RGD peptide-based PET probes. Am J Nucl Med Mol Imaging. 2013; 3(1):97-101. PMID: 23342304; PMCID: PMC3545367.
    45. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 07; 10(1):329-36. PMID: 23211050; PMCID: PMC3540204.
    46. Chen K, Ma W, Li G, Wang J, Yang W, Yap LP, Hughes LD, Park R, Conti P. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Mol Pharm. 2013 Jan 07; 10(1):417-27. PMID: 23190134.
      View in: PubMed
    47. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti P. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment. Mol Imaging Biol. 2012 Dec; 14(6):718-24. PMID: 22476968.
      View in: PubMed
    48. Huang CW, Li Z, Conti P. Radioactive smart probe for potential corrected matrix metalloproteinase imaging. Bioconjug Chem. 2012 Nov 21; 23(11):2159-67. PMID: 23025637.
      View in: PubMed
    49. Chen K, Wang X, Lin WY, Shen CK, Yap LP, Hughes LD, Conti P. Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes. ACS Med Chem Lett. 2012 Dec 13; 3(12):1019-23. PMID: 24900423; PMCID: PMC4025793.
    50. Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti P, Chen TC, Longo VD. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One. 2012; 7(9):e44603. PMID: 22984531; PMCID: PMC3439413.
    51. Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. Mol Imaging. 2012 Sep-Oct; 11(5):426-32. PMID: 22954187; PMCID: PMC3443080.
    52. Kong N, Lan Q, Su W, Chen M, Wang J, Yang Z, Park R, Dagliyan G, Conti P, Brand D, Liu Z, Stohl W, Zou H, Zheng SG. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis. 2012 Sep; 71(9):1567-1572. PMID: 22764040; PMCID: PMC4038329.
    53. Jadvar H, Desai B, Ji L, Conti P, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Clin Nucl Med. 2012 Jul; 37(7):637-43. PMID: 22691503; PMCID: PMC3375600.
    54. Ley EJ, Clond MA, Bukur M, Park R, Chervonski M, Dagliyan G, Margulies DR, Lyden PD, Conti P, Salim A. ß-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg. 2012 Jul; 73(1):33-40. PMID: 22743370.
      View in: PubMed
    55. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti P. The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals. Theranostics. 2012; 2(6):589-96. PMID: 22737194; PMCID: PMC3381345.
    56. Ng TS, Bading JR, Park R, Sohi H, Procissi D, Colcher D, Conti P, Cherry SR, Raubitschek AA, Jacobs RE. Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner. J Nucl Med. 2012 Jul; 53(7):1102-9. PMID: 22661534; PMCID: PMC3552656.
    57. Chen K, Li Z, Conti P. Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-d-arabinofuranosyluracil ([18F]-FMAU). Nucl Med Biol. 2012 Oct; 39(7):1019-25. PMID: 22503457.
      View in: PubMed
    58. Chen K, Sun X, Niu G, Ma Y, Yap LP, Hui X, Wu K, Fan D, Conti P, Chen X. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Mol Imaging Biol. 2012 Feb; 14(1):96-105. PMID: 21360213.
      View in: PubMed
    59. Sahu D, Zhao Z, Tsen F, Cheng CF, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS, Conti P, Woodley DT, Li W. A potentially common peptide target in secreted heat shock protein-90a for hypoxia-inducible factor-1a-positive tumors. Mol Biol Cell. 2012 Feb; 23(4):602-13. PMID: 22190738; PMCID: PMC3279389.
    60. Li D, Shan H, Conti P, Li Z. PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Am J Nucl Med Mol Imaging. 2012; 2(1):29-32. PMID: 23133800; PMCID: PMC3478119.
    61. Li Z, Jin Q, Huang C, Dasa S, Chen L, Yap LP, Liu S, Cai H, Park R, Conti P. Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging. Theranostics. 2011; 1:371-80. PMID: 22211143; PMCID: PMC3248641.
    62. Huang CW, Li Z, Conti P. In vivo near-infrared fluorescence imaging of integrin a2ß1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe. J Nucl Med. 2011 Dec; 52(12):1979-86. PMID: 22065876.
      View in: PubMed
    63. Liu S, Li Z, Yap LP, Huang CW, Park R, Conti P. Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals. Chemistry. 2011 Sep 05; 17(37):10222-5. PMID: 21815227.
      View in: PubMed
    64. Li Z, Lin TP, Liu S, Huang CW, Hudnall TW, Gabbaï FP, Conti P. Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging. Chem Commun (Camb). 2011 Sep 07; 47(33):9324-6. PMID: 21779546.
      View in: PubMed
    65. Graham M, Conti P, Hoffman J. SNM clinical trials network validates 100th scanner. J Nucl Med. 2011 Jun; 52(6):25N. PMID: 21622892.
      View in: PubMed
    66. Selvaraj R, Liu S, Hassink M, Huang CW, Yap LP, Park R, Fox JM, Li Z, Conti P. Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin avß3 targeted PET tracer based on a cyclic RGD peptide. Bioorg Med Chem Lett. 2011 Sep 01; 21(17):5011-4. PMID: 21601452; PMCID: PMC3230322.
    67. Zissen MH, Kunz P, Subbarayan M, Chin FT, Conti P, Fisher GA, Quon A. 18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. Nucl Med Commun. 2011 May; 32(5):343-7. PMID: 21412178.
      View in: PubMed
    68. Huang CW, Li Z, Cai H, Shahinian T, Conti P. Novel a(2)ß(1) integrin-targeted peptide probes for prostate cancer imaging. Mol Imaging. 2011 Aug; 10(4):284-94. PMID: 21486537.
      View in: PubMed
    69. Cai H, Li Z, Conti P. The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy. Nucl Med Biol. 2011 Jul; 38(5):659-66. PMID: 21718941.
      View in: PubMed
    70. Huang CW, Li Z, Cai H, Chen K, Shahinian T, Conti P. Design, synthesis and validation of integrin a2ß1-targeted probe for microPET imaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2011 Jul; 38(7):1313-22. PMID: 21350963.
      View in: PubMed
    71. Huang CW, Li Z, Cai H, Shahinian T, Conti P. Biological stability evaluation of the a2ß1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide. Bioconjug Chem. 2011 Feb 16; 22(2):256-63. PMID: 21244039.
      View in: PubMed
    72. Chen K, Yap LP, Park R, Hui X, Wu K, Fan D, Chen X, Conti P. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Amino Acids. 2012 Apr; 42(4):1329-37. PMID: 21212998.
      View in: PubMed
    73. Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P, Scott AM, Macfarlane D, Fine BM, Hicks RJ. Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2011 Apr; 38(4):642-50. PMID: 21207024.
      View in: PubMed
    74. Cai H, Li Z, Huang CW, Park R, Conti P. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin avß3 expression. Curr Radiopharm. 2011 Jan; 4(1):68-74. PMID: 22191616.
      View in: PubMed
    75. Li Z, Cai H, Conti P. Improved synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]FMAU). Curr Radiopharm. 2011 Jan; 4(1):24-30. PMID: 22191612.
      View in: PubMed
    76. Li Z, Cai H, Conti P. Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module. Nucl Med Biol. 2011 Feb; 38(2):201-6. PMID: 21315275.
      View in: PubMed
    77. Graham M, Conti P, Hoffman J. Clinical trials network strives for standardization. J Nucl Med. 2010 Nov; 51(11):15N. PMID: 21051645.
      View in: PubMed
    78. Li Z, Cai H, Hassink M, Blackman ML, Brown RC, Conti P, Fox JM. Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes. Chem Commun (Camb). 2010 Nov 14; 46(42):8043-5. PMID: 20862423; PMCID: PMC3230320.
    79. Li Z, Conti P. Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1031-51. PMID: 20854860.
      View in: PubMed
    80. Chen K, Conti P. Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1005-22. PMID: 20851156.
      View in: PubMed
    81. Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti P. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Bioconjug Chem. 2010 Aug 18; 21(8):1417-24. PMID: 20666401.
      View in: PubMed
    82. Lacruz RS, Nanci A, White SN, Wen X, Wang H, Zalzal SF, Luong VQ, Schuetter VL, Conti P, Kurtz I, Paine ML. The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition. J Biol Chem. 2010 Aug 06; 285(32):24432-8. PMID: 20529845; PMCID: PMC2915679.
    83. Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti P, Margulies DR, Salim A. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010 Feb; 68(2):353-6. PMID: 20154548.
      View in: PubMed
    84. Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti P. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. Nucl Med Biol. 2010 Jan; 37(1):57-65. PMID: 20122669.
      View in: PubMed
    85. Li Z, Li Q, Pantazis D, Yu X, Conti P, Leahy RM. Controlling familywise error rate for matched subspace detection in dynamic FDG PET. IEEE Trans Med Imaging. 2009 Oct; 28(10):1623-31. PMID: 19783499.
      View in: PubMed
    86. McEwan AS, Graham MM, Conti P. Site qualification in multicenter clinical trials. J Nucl Med. 2009 Aug; 50(8):30N. PMID: 19652215.
      View in: PubMed
    87. Cai H, Fissekis J, Conti P. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling. Dalton Trans. 2009 Jul 21; (27):5395-400. PMID: 19565091.
      View in: PubMed
    88. McEwan AS, Graham MM, Conti P. SNM molecular imaging summit introduces clinical trials network. J Nucl Med. 2009 Apr; 50(4):18N. PMID: 19339670.
      View in: PubMed
    89. Li Z, Li Q, Yu X, Conti P, Leahy RM. Lesion detection in dynamic FDG-PET using matched subspace detection. IEEE Trans Med Imaging. 2009 Feb; 28(2):230-40. PMID: 19188110.
      View in: PubMed
    90. Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti P, Margulies DR, Salim A. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009 Jan; 66(1):154-9; discussion 159-61. PMID: 19131818.
      View in: PubMed
    91. Bischof Delaloye A, Conti P, Gisselbrecht C, Gregory SA. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction. Oncologist. 2009; 14 Suppl 2:1-3. PMID: 19819919.
      View in: PubMed
    92. Bischof Delaloye A, Conti P, Gisselbrecht C, Gregory SA. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary. Oncologist. 2009; 14 Suppl 2:52-4. PMID: 19819924.
      View in: PubMed
    93. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti P. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist. 2009; 14 Suppl 2:30-40. PMID: 19819922.
      View in: PubMed
    94. Jadvar H, Ye W, Groshen S, Conti P. [F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland. Ann Nucl Med. 2008 Nov; 22(9):787-93. PMID: 19039557; PMCID: PMC2636719.
    95. Wen X, Zou Y, Luo W, Goldberg M, Moats R, Conti P, Snead ML, Paine ML. Biglycan overexpression on tooth enamel formation in transgenic mice. Anat Rec (Hoboken). 2008 Oct; 291(10):1246-53. PMID: 18727043; PMCID: PMC2562349.
    96. Conti P, McEwan AJ, Pomper MG. Molecular imaging: the future of modern medicine. J Nucl Med. 2008 Jun; 49(6):16N-20N. PMID: 18511813.
      View in: PubMed
    97. Jadvar H, Gurbuz A, Li X, Shahinian A, Conti P. Choline autoradiography of human prostate cancer xenograft: effect of castration. Mol Imaging. 2008 May-Jun; 7(3):147-52. PMID: 19123985; PMCID: PMC2621313.
    98. Jadvar H, Quan V, Henderson RW, Conti P. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol. 2008 Feb; 13(1):42-7. PMID: 18307018; PMCID: PMC2295284.
    99. Ulaner GA, Colletti PM, Conti P. B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience. Radiology. 2008 Mar; 246(3):895-902. PMID: 18258810.
      View in: PubMed
    100. Iagaru A, Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti P. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. Clin Nucl Med. 2008 Jan; 33(1):8-13. PMID: 18097248.
      View in: PubMed
    101. Conti P, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET. Nucl Med Biol. 2008 Jan; 35(1):131-41. PMID: 18158952.
      View in: PubMed
    102. Wiseman GA, Conti P, Vo K, Schilder RJ, Gordon LI, Emmanouilides C, Silverman DH, Witzig TE, Darif M, Molina A. Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Clin Lymphoma Myeloma. 2007 Sep; 7(8):514-7. PMID: 18021468.
      View in: PubMed
    103. Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti P, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res. 2007 Aug 01; 67(15):7525-33. PMID: 17671224.
      View in: PubMed
    104. Jadvar H, Henderson RW, Conti P. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007 Mar-Apr; 31(2):223-8. PMID: 17414758.
      View in: PubMed
    105. Iagaru A, Masamed R, Singer PA, Conti P. Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. Mol Imaging Biol. 2007 Mar-Apr; 9(2):72-7. PMID: 17186139.
      View in: PubMed
    106. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives. Nucl Med Biol. 2007 Apr; 34(3):267-72. PMID: 17383576; PMCID: PMC1905838.
    107. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007 Jun; 34(6):822-9. PMID: 17206416.
      View in: PubMed
    108. Iagaru A, Masamed R, Keesara S, Conti P. Breast MRI and 18F FDG PET/CT in the management of breast cancer. Ann Nucl Med. 2007 Jan; 21(1):33-8. PMID: 17373334.
      View in: PubMed
    109. Iagaru A, Chawla S, Menendez L, Conti P. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun. 2006 Oct; 27(10):795-802. PMID: 16969262.
      View in: PubMed
    110. Iagaru A, Masamed R, Singer PA, Conti P. 2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer. Mol Imaging Biol. 2006 Sep-Oct; 8(5):309-14. PMID: 16758370.
      View in: PubMed
    111. Sodir NM, Chen X, Park R, Nickel AE, Conti P, Moats R, Bading JR, Shibata D, Laird PW. Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res. 2006 Sep 01; 66(17):8430-8. PMID: 16951153.
      View in: PubMed
    112. Jadvar H, Henderson RW, Conti P. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol. 2006 May-Jun; 8(3):193-200. PMID: 16565910.
      View in: PubMed
    113. Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti P. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide. Mol Imaging Biol. 2006 Jan-Feb; 8(1):9-15. PMID: 16315003.
      View in: PubMed
    114. Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti P, Smith DJ, Cherry SR, Leahy RM. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys Med Biol. 2005 Dec 07; 50(23):5421-41. PMID: 16306643.
      View in: PubMed
    115. Conti P, White C, Pieslor P, Molina A, Aussie J, Foster P. The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. J Nucl Med. 2005 Nov; 46(11):1812-8. PMID: 16269594.
      View in: PubMed
    116. Coleman RE, Delbeke D, Guiberteau MJ, Conti P, Royal HD, Weinreb JC, Siegel BA, Federle MP, Townsend DW, Berland LL. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Am Coll Radiol. 2005 Jul; 2(7):568-84. PMID: 17411882.
      View in: PubMed
    117. Coleman RE, Delbeke D, Guiberteau MJ, Conti P, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med. 2005 Jul; 46(7):1225-39. PMID: 16000293.
      View in: PubMed
    118. Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, Conti P. Glucose metabolism of human prostate cancer mouse xenografts. Mol Imaging. 2005 Apr-Jun; 4(2):91-7. PMID: 16105512.
      View in: PubMed
    119. Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, Bremner R, Bading JR, Conti P. Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia. 2005 Mar; 7(3):271-9. PMID: 15799827; PMCID: PMC1501139.
    120. Conti P. The future of radioimmunotherapy: a PET perspective. Semin Oncol. 2005 Feb; 32(1 Suppl 1):S63-7. PMID: 15786028.
      View in: PubMed
    121. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J Nucl Med. 2004 Dec; 45(12):2063-9. PMID: 15585483.
      View in: PubMed
    122. Cham D, Henderson R, Conti P. Virchow's node on F-18 FDG PET/CT. Clin Nucl Med. 2004 Nov; 29(11):770-2. PMID: 15483511.
      View in: PubMed
    123. Chen X, Conti P, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004 Nov 01; 64(21):8009-14. PMID: 15520209.
      View in: PubMed
    124. Jadvar H, Conti P. The reproductive tract. Semin Nucl Med. 2004 Oct; 34(4):262-73. PMID: 15493004.
      View in: PubMed
    125. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti P. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med. 2004 Oct; 45(10):1776-83. PMID: 15471848.
      View in: PubMed
    126. Jadvar H, Gamie S, Ramanna L, Conti P. Musculoskeletal system. Semin Nucl Med. 2004 Oct; 34(4):254-61. PMID: 15493003.
      View in: PubMed
    127. Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti P. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol. 2004 Sep-Oct; 6(5):350-9. PMID: 15380745.
      View in: PubMed
    128. Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti P. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. J Nucl Med. 2004 Aug; 45(8):1390-7. PMID: 15299066.
      View in: PubMed
    129. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol. 2004 May; 31(4):399-405. PMID: 15093809.
      View in: PubMed
    130. Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti P. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol. 2004 May; 31(4):407-18. PMID: 15093810.
      View in: PubMed
    131. Chen X, Park R, Hou Y, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Bading JR, Laug WE, Conti P. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur J Nucl Med Mol Imaging. 2004 Aug; 31(8):1081-9. PMID: 15118844.
      View in: PubMed
    132. Chen X, Tohme M, Park R, Hou Y, Bading JR, Conti P. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging. 2004 Apr; 3(2):96-104. PMID: 15296674.
      View in: PubMed
    133. Alauddin MM, Shahinian A, Gordon EM, Conti P. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol Imaging. 2004 Apr; 3(2):76-84. PMID: 15296672.
      View in: PubMed
    134. Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti P. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 2004 Feb; 31(2):179-89. PMID: 15013483.
      View in: PubMed
    135. Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti P. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjug Chem. 2004 Jan-Feb; 15(1):41-9. PMID: 14733582.
      View in: PubMed
    136. Chen X, Park R, Shahinian AH, Bading JR, Conti P. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. Nucl Med Biol. 2004 Jan; 31(1):11-9. PMID: 14741566.
      View in: PubMed
    137. Conti P. Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician. Semin Nucl Med. 2004 Jan; 34(1 Suppl 1):2-3. PMID: 14762737.
      View in: PubMed
    138. Jadvar H, Pinski JK, Conti P. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep. 2003 Sep-Oct; 10(5):1485-8. PMID: 12883728.
      View in: PubMed
    139. Bading JR, Yoo PB, Fissekis JD, Alauddin MM, D'Argenio DZ, Conti P. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats. Cancer Res. 2003 Jul 01; 63(13):3667-74. PMID: 12839957.
      View in: PubMed
    140. Alauddin MM, Louie AY, Shahinian A, Meade TJ, Conti P. Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. Nucl Med Biol. 2003 Apr; 30(3):261-5. PMID: 12745017.
      View in: PubMed
    141. Jadvar H, Conti P. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002 Dec; 31(12):690-4. PMID: 12483429.
      View in: PubMed
    142. Tatlidil R, Jadvar H, Bading JR, Conti P. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002 Sep; 224(3):783-7. PMID: 12202714.
      View in: PubMed
    143. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti P, Blasberg RG. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 2002 Aug; 43(8):1072-83. PMID: 12163634.
      View in: PubMed
    144. Alauddin MM, Shahinian A, Gordon EM, Conti P. Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2002 Apr-Jun; 1(2):74-81. PMID: 12920847.
      View in: PubMed
    145. Wagner HN, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, Lamonica DM, Conti P. Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody. J Nucl Med. 2002 Feb; 43(2):267-72. PMID: 11850494.
      View in: PubMed